Barclays PLC Omnicell, Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Omnicell, Inc stock. As of the latest transaction made, Barclays PLC holds 339,536 shares of OMCL stock, worth $15.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

339,536

Previous 339,536 -0.0%

Holding current value

$15.3 Million

Previous $14.8 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$25.61 - $45.43 $3.12 Million - $5.54 Million	122,001 Added 56.08%	339,536 $14.8 Million
Q2 2024 Aug 14, 2024	BUY	$26.22 - $32.65 $1.56 Million - $1.94 Million	59,454 Added 37.61%	217,535 $5.89 Million
Q1 2024 May 15, 2024	BUY	$26.15 - $37.33 $1.39 Million - $1.98 Million	53,047 Added 50.5%	158,081 $4.62 Million
Q4 2023 Feb 15, 2024	BUY	$29.24 - $45.81 $1.78 Million - $2.79 Million	60,855 Added 137.75%	105,034 $3.95 Million
Q3 2023 Nov 07, 2023	SELL	$44.6 - $73.38 $3.38 Million - $5.55 Million	-75,690 Reduced 63.14%	44,179 $1.99 Million
Q2 2023 Aug 03, 2023	BUY	$57.88 - $75.94 $1.29 Million - $1.69 Million	22,252 Added 22.8%	119,869 $8.83 Million
Q1 2023 May 04, 2023	BUY	$51.51 - $60.43 $1.79 Million - $2.1 Million	34,796 Added 55.39%	97,617 $5.73 Million
Q4 2022 Feb 13, 2023	SELL	$46.24 - $90.03 $1.63 Million - $3.18 Million	-35,332 Reduced 36.0%	62,821 $3.17 Million
Q3 2022 Nov 03, 2022	SELL	$84.23 - $117.38 $419,296 - $584,317	-4,978 Reduced 4.83%	98,153 $8.54 Million
Q2 2022 Aug 12, 2022	SELL	$105.64 - $129.11 $1.58 Million - $1.93 Million	-14,948 Reduced 12.66%	103,131 $11.7 Million
Q1 2022 May 16, 2022	SELL	$120.68 - $180.51 $23,894 - $35,740	-198 Reduced 0.17%	118,079 $15.3 Million
Q4 2021 Feb 14, 2022	SELL	$153.26 - $183.62 $2.56 Million - $3.07 Million	-16,701 Reduced 12.37%	118,277 $21.3 Million
Q3 2021 Nov 09, 2021	BUY	$141.84 - $160.88 $11.9 Million - $13.5 Million	84,004 Added 164.8%	134,978 $20 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $151.45 $6.67 Million - $7.78 Million	-51,364 Reduced 50.19%	50,974 $7.72 Million
Q1 2021 May 13, 2021	BUY	$117.78 - $143.9 $4.02 Million - $4.91 Million	34,141 Added 50.06%	102,338 $13.3 Million
Q4 2020 Feb 11, 2021	SELL	$73.85 - $120.02 $65,209 - $105,977	-883 Reduced 1.28%	68,197 $8.19 Million
Q3 2020 Nov 12, 2020	BUY	$63.15 - $77.12 $1.04 Million - $1.28 Million	16,539 Added 31.48%	69,080 $5.16 Million
Q2 2020 Aug 12, 2020	BUY	$59.36 - $74.43 $517,678 - $649,104	8,721 Added 19.9%	52,541 $3.71 Million
Q1 2020 May 13, 2020	SELL	$55.41 - $90.19 $1.57 Million - $2.56 Million	-28,379 Reduced 39.31%	43,820 $2.87 Million
Q4 2019 Feb 10, 2020	BUY	$70.15 - $83.11 $2.21 Million - $2.61 Million	31,441 Added 77.14%	72,199 $5.9 Million
Q3 2019 Nov 14, 2019	SELL	$68.36 - $88.34 $809,040 - $1.05 Million	-11,835 Reduced 22.5%	40,758 $2.95 Million
Q2 2019 Aug 14, 2019	BUY	$71.38 - $92.21 $1.37 Million - $1.77 Million	19,144 Added 57.23%	52,593 $4.52 Million
Q1 2019 May 15, 2019	BUY	$58.88 - $86.19 $846,871 - $1.24 Million	14,383 Added 75.44%	33,449 $2.7 Million
Q4 2018 Feb 14, 2019	SELL	$56.97 - $77.23 $1.24 Million - $1.68 Million	-21,703 Reduced 53.23%	19,066 $1.17 Million
Q3 2018 Nov 14, 2018	BUY	$52.65 - $71.9 $1.4 Million - $1.91 Million	26,584 Added 187.41%	40,769 $2.93 Million
Q2 2018 Aug 14, 2018	SELL	$42.2 - $53.05 $58,658 - $73,739	-1,390 Reduced 8.92%	14,185 $744,000
Q1 2018 May 15, 2018	BUY	$40.1 - $52.45 $372,128 - $486,736	9,280 Added 147.42%	15,575 $677,000
Q4 2017 Feb 14, 2018	BUY	$45.3 - $54.5 $246,658 - $296,752	5,445 Added 640.59%	6,295 $305,000
Q3 2017 Nov 14, 2017	BUY	$48.1 - $52.15 $40,885 - $44,327	850	850 $43,000

Others Institutions Holding OMCL

# of Institutions

277

Shares Held

44.6M

Call Options Held

224K

Put Options Held

35.7K

View Full List

About OMNICELL, Inc

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $2B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

More about OMCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account